Archive: 25/07/2015

FDA approves odomzo for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat patients with locally advanced basal cell carcinoma that has returned despite surgery or radiation, or who are not candidates ...

Jul 25, 2015

0

14

'Driving straight' may be suitable road test in dementia

(HealthDay)—Drivers with dementia who have more difficulties driving straight and making left and right turns are more likely to fail road testing, according to a study published in the July issue of the Journal of the ...

Jul 25, 2015

0

60

Mouse model of head transplantation is promising

(HealthDay)—The mouse model of allo-head and body reconstruction (AHBR) is feasible for avoiding brain ischemia during transplantation, according to a study published in the August issue of CNS Neuroscience & Therapeutics.

Jul 25, 2015

0

44

Climate change may be pushing 'Brain-eating' amoeba to northern lakes

(HealthDay)—A deadly "brain-eating" amoeba that lives in freshwater sources may be surviving in more northern areas of the United States thanks to climate change, health experts suggest.

Jul 25, 2015

0

106

US regulators give limited approval to cholesterol drug

US regulators on Friday approved a new cholesterol drug called Praluent, made by Sanofi and Regeneron, for people with certain genetic risk factors for heart disease.

Jul 25, 2015

Does concussion impact men and women differently?

New research suggests concussion may not significantly impair symptoms or cognitive skills for one gender over another, however, women may still experience greater symptoms and poorer cognitive performance at preseason testing. ...

Jul 25, 2015

page 2 from 2

«
»